FH and hereditary leiomyomatosis and renal cell cancer: Its (bi-allelic) mutation and/or deletion is considered the main molecular event in FH-deficient RCC, formerly classified as hereditary leiomyomatosis and renal cell carcinoma RCC (HLRCC-RCC).